Back
Seres Therapeutics Stock Price Chart
Sponsored
Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Sell
43
MCRB
Seres Therapeutics
Last Price:
5.65
Seasonality Move:
-6.67%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Global Leader In Plant Cell Biology Poised For Rapid Growth!
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!- The current trend is relatively stagnant and MCRB is experiencing slight buying pressure.
Seres Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.46 | Buy |
| 20-day SMA: | 5.38 | Buy |
| 50-day SMA: | 5.85 | Sell |
| 200-day SMA: | 5.3 | Buy |
| 8-day EMA: | 5.45 | Buy |
| 20-day EMA: | 5.46 | Buy |
| 50-day EMA: | 5.77 | Sell |
| 200-day EMA: | 6.26 | Sell |
Seres Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 48.63 | Sell |
| Chaikin Money Flow: | 213521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.23 - 5.53) | Buy |
| Bollinger Bands (100): | (5.5 - 7.26) | Sell |
Seres Therapeutics Technical Analysis
| Jan-19 | Jan-20 | Jan-23 | Jan-24 | Jan-25 | Jan-26 | Jan-27 | Jan-30 | Jan-31 | Feb-1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics Stock
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 5.49 while MCRB 8-day simple moving average is 5.46, which is a Buy signal.
- The stock price of MCRB is 5.49 while Seres Therapeutics 20-day SMA is 5.38, which makes it a Buy.
- Seres Therapeutics 50-day simple moving average is 5.85 while MCRB share price is 5.49, making it a Sell technically.
- MCRB stock price is 5.49 and Seres Therapeutics 200-day simple moving average is 5.30, creating a Buy signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
43
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a Sell
The current Seres Therapeutics [MCRB] share price is $5.49. The Score for MCRB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics Stock Info
Market Cap:
684.01M
Price in USD:
5.49
Share Volume:
896.79K
Seres Therapeutics 52-Week Range
52-Week High:
9.49
52-Week Low:
2.50
Sell
43
Seres Therapeutics (MCRB)
is a Sell
Seres Therapeutics Share Price Forecast
-
What is the Seres Therapeutics stock price today?
The Seres Therapeutics stock price is 5.49 USD today. -
Will MCRB stock go up or go down?
Seres Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seres Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics is overvalued.
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 5.49 while MCRB 8-day exponential moving average is 5.45, which is a Buy signal.
- The stock price of MCRB is 5.49 while Seres Therapeutics 20-day EMA is 5.46, which makes it a Buy.
- Seres Therapeutics 50-day exponential moving average is 5.77 while MCRB share price is 5.49, making it a Sell technically.
- MCRB stock price is 5.49 and Seres Therapeutics 200-day simple moving average is 6.26, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics
Is Seres Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.11 per share, and an increase next year of $0.60 per share.
Technical Analysis of Seres Therapeutics
Should I short Seres Therapeutics stock?
- MCRB Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Seres Therapeutics is a Sell
- Seres Therapeutics Relative Strength Index (RSI) is 48.63, which suggest Seres Therapeutics is oversold
- The Bollinger Bands (25) for Seres Therapeutics is (5.23 - 5.53), which suggest Seres Therapeutics is a Sell
- The Bollinger Bands (100) for Seres Therapeutics is (5.5 - 7.26), which suggest Seres Therapeutics is a Sell
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.